Lexicon is evaluating the safety and efficacy of sotagliflozin in patients with both obstructive and non-obstructive hypertrophic cardiomyopathy (HCM) Pivotal Phase 3 clinical trial is actively ...

If you have cancer, you expect to see an oncologist, but if you have heart failure you may or may not see a cardiologist.

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

People with irregular sleep schedules had a 26% higher risk of major cardiovascular events, even if they got the recommended ...

If you have cancer, you expect to see an oncologist, but if you have heart failure you may or may not see a cardiologist.

Tailoring the number of consults based on HF severity, which can be assessed pragmatically, could pay dividends, say ...

If you have cancer, you expect to see an oncologist, but if you have heart failure you may or may not see a cardiologist. According to research ...

CellProthera will tech transfer to CELLforCURE by SEQENS this year, with plans to produce clinical batches starting in 2026.

CellProthera says it chose CELLforCURE by SEQENS as its CDMO for the quality of its infrastructure, equipment, and expertise of its team.

Broken heart syndrome” carries a significant risk of death and serious complications. Although the condition appears to be ...

Recombinant zoster vaccine reduces all-cause mortality in patients with immune-mediated inflammatory diseases receiving Janus ...